Literature DB >> 15763193

Uveal melanoma: epidemiologic aspects.

Arun D Singh1, Louise Bergman, Stefan Seregard.   

Abstract

Melanomas of the ocular and adnexal structures comprise approximately 5% of all melanomas. The majority (85%) of ocular melanomas are uveal in origin; primary conjunctival and orbital melanomas are rare. The diagnosis of uveal melanoma is made by clinical examination including indirect ophthalmoscopy and by ancillary studies such as fluorescein angiography and ultrasonography. Metastases to the liver develop within 15 years after the initial diagnosis and treatment in approximately 50% of patients with posterior uveal melanoma; however, clinically evident metastatic disease at the time of initial presentation is uncommon, indicating that there is early subclinical metastasis in most cases.

Entities:  

Mesh:

Year:  2005        PMID: 15763193     DOI: 10.1016/j.ohc.2004.07.002

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  102 in total

1.  A pilot study of bevacizumab and interferon-α2b in ocular melanoma.

Authors:  Kristan D Guenterberg; Valerie P Grignol; Kiran V Relekar; Kimberly A Varker; Helen X Chen; Kari L Kendra; Thomas E Olencki; William E Carson
Journal:  Am J Clin Oncol       Date:  2011-02       Impact factor: 2.339

2.  Identify the signature genes for diagnose of uveal melanoma by weight gene co-expression network analysis.

Authors:  Kai Shi; Zhi-Tong Bing; Gui-Qun Cao; Ling Guo; Ya-Na Cao; Hai-Ou Jiang; Mei-Xia Zhang
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

3.  Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma.

Authors:  Dominic Lapadula; Eduardo Farias; Clinita E Randolph; Timothy J Purwin; Dougan McGrath; Thomas H Charpentier; Lihong Zhang; Shihua Wu; Mizue Terai; Takami Sato; Gregory G Tall; Naiming Zhou; Philip B Wedegaertner; Andrew E Aplin; Julio Aguirre-Ghiso; Jeffrey L Benovic
Journal:  Mol Cancer Res       Date:  2018-12-19       Impact factor: 5.852

4.  Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.

Authors:  Peter W Chen; Jessamee K Mellon; Elizabeth Mayhew; Shixuan Wang; Yu Guang He; Nick Hogan; Jerry Y Niederkorn
Journal:  Exp Eye Res       Date:  2007-07-25       Impact factor: 3.467

Review 5.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

6.  Reduced expression of autotaxin predicts survival in uveal melanoma.

Authors:  Arun D Singh; Karen Sisley; Yaomin Xu; Jianbo Li; Pieter Faber; Sarah J Plummer; Hardeep S Mudhar; Ian G Rennie; Patricia M Kessler; Graham Casey; Bryan G Williams
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

7.  Uveal melanoma: evaluation of extrascleral extension using thin-section MR of the eye with surface coils.

Authors:  Tommaso Tartaglione; Monica Maria Pagliara; Mariacarmela Sciandra; Carmela Grazia Caputo; Rosalinda Calandrelli; Gina Fabrizi; Simona Gaudino; Maria Antonietta Blasi; Cesare Colosimo
Journal:  Radiol Med       Date:  2014-01-28       Impact factor: 3.469

8.  Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization.

Authors:  Shinji Ozaki; Raja Vuyyuru; Ken Kageyama; Mizue Terai; Masahiro Ohara; Hanyin Cheng; Tim Manser; Michael J Mastrangelo; Andrew E Aplin; Takami Sato
Journal:  Am J Pathol       Date:  2015-11-25       Impact factor: 4.307

9.  Genetics of uveal melanoma and cutaneous melanoma: two of a kind?

Authors:  Thomas van den Bosch; Emine Kilic; Dion Paridaens; Annelies de Klein
Journal:  Dermatol Res Pract       Date:  2010-06-06

10.  Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.

Authors:  Catherine D Van Raamsdonk; Vladimir Bezrookove; Gary Green; Jürgen Bauer; Lona Gaugler; Joan M O'Brien; Elizabeth M Simpson; Gregory S Barsh; Boris C Bastian
Journal:  Nature       Date:  2008-12-10       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.